Johnson & Johnson, Drug Distributors Settle $26 Bln Opioid Deal

强生公司,药品经销商达成26美元阿片类药物交易

2021-07-22 12:31:04 RTTNews

本文共793个字,阅读需2分钟

A council of state attorneys general said on Wednesday that a landmark $26 billion settlement has been decided upon, thus settling claims that the three largest U.S. drug distributors, namely McKesson Corp. (MCK), Cardinal Health (CAH) and AmerisourceBergen (ABC) along with drug maker Johnson & Johnson (JNJ) were responsible for a deadly nationwide opioid epidemic. As per the settlement agreement, the three drug distributors will pay a combined amount of $21 billion, while Johnson & Johnson would pay a sum of $5 billion. The break-up of the amount among the three distributors is as follows- AmerisourceBergen: $6.4 billion, Cardinal Health: $6.4 billion and McKesson: $7.9 billion. The state attorneys general council said that the three distributors would pay the amount over a period of 18 years, while Johnson & Johnson would settle the amount in 9 years, with a sum of $3.7 billion being paid in the first three years. The opioid crisis is said to be the reason behind many deaths in the U.S due to overdose since the year 1999. All the three drug distributors have been blamed for lax controls, which allowed the flow of large amounts of addictive painkillers to reach illegal channels thus leading to many deaths by drug overdose. Johnson & Johnson has been accused of not spreading enough awareness about the addiction risk of its opioid marketing. All the accused companies have denied the allegations. In a statement issued on Wednesday, the three drug makers said that while they strongly deny the allegations made against them, they believe that the settlement agreement reached upon with the state attorney generals will be a major step ahead in closing the many lawsuits filed across different states. The settlement will also bring meaningful relief to communities across the United States, the statement added. In the settlement, clauses have also been made for the setting up of an independent clearinghouse to supply information to all the three distributors and state regulators as to where the drugs are being distributed and how often. This clearinghouse, according to the government, will help bring down the number of pills being over shipped to communities. As per reports, the final amount which the companies will have to pay is dependent on how many states across the U.S sign up for the settlement and confirm their cities and areas on board. For the states to receive any form of money, atleast 44 states must be signatories of the deal. States have been given a 30 day time frame to decide upon whether they are on board with the agreement or not. According to reports, more than 3,000 lawsuits related to this health crisis have been filed across the country by state and local governments so it is important for them to come to some of sort of agreement to resolve the issue. For comments and feedback contact: editorial@rttnews.com Business News
一个州司法部长委员会周三表示,一项里程碑式的260亿美元和解协议已经决定,从而解决了美国三大药品分销商,即麦克森公司(MCK)、红衣主教健康公司(CAH)和美国制药商强生公司(ABC)对全国性致命的阿片类药物流行病负有责任的指控。根据和解协议,三家药品分销商将支付总额为210亿美元,而强生公司将支付50亿美元。三家分销商之间的金额分成如下--美国证券公司:64亿美元,红衣主教健康公司:64亿美元,麦肯森公司:79亿美元。州总检察长委员会表示,三家经销商将在18年内支付这笔款项,而强生公司将在9年内结算这笔款项,前三年支付37亿美元。据说阿片危机是自1999年以来美国许多人因用药过量而死亡的原因。这三家药品分销商都被指责控制不严,导致大量令人上瘾的止痛药流入非法渠道,从而导致许多人因吸毒过量而死亡。强生公司被指控没有对其阿片类药物营销的成瘾风险传播足够的意识。所有被指控的公司都否认了这些指控。在周三发表的一份声明中,这三家制药商表示,尽管他们强烈否认对他们的指控,但他们认为,与州司法部长达成的和解协议将是结束不同州提起的许多诉讼的重要一步。声明补充说,该解决方案还将给美国各地的社区带来有意义的缓解。在和解协议中,还规定建立一个独立的信息交换所,向所有三个分销商和州监管机构提供关于药物分销地点和频率的信息。根据政府的说法,这个信息交换所将有助于减少向社区过度运输的药丸数量。据报道,这些公司必须支付的最终金额取决于美国有多少州签署了和解协议,并确认了他们的城市和地区。为了让各州获得任何形式的资金,至少44个州必须是该协议的签署国。各国有30天的时间来决定是否加入该协议。据报道,各州和地方政府在全国范围内提起了3000多起与这场健康危机有关的诉讼,因此他们达成某种协议来解决这个问题很重要。 如需评论和反馈,请联系:editorial@rttnews.com 商业新闻

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文